相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Predicting the profile of increasing disability in multiple sclerosis
Valentina Tomassini et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
TNFR signalling and its clinical implications
Wen-Yi Tseng et al.
CYTOKINE (2018)
A New Venue of TNF Targeting
Sophie Steeland et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Elevated plasma homocysteine levels are associated with disability progression in patients with multiple sclerosis
Sayonara Rangel Oliveira et al.
METABOLIC BRAIN DISEASE (2018)
Role of TNF-TNF Receptor 2 Signal in Regulatory T Cells and Its Therapeutic Implications
Sujuan Yang et al.
FRONTIERS IN IMMUNOLOGY (2018)
Selective Modulation of TnF-TnFRs Signaling: insights for Multiple Sclerosis Treatment
Valentina Pegoretti et al.
FRONTIERS IN IMMUNOLOGY (2018)
Tumor Necrosis Factor α and Regulatory T Cells in Oncoimmunology
Benoit L. Salomon et al.
FRONTIERS IN IMMUNOLOGY (2018)
Cytokine Profile in Patients with Progressive Multiple Sclerosis and Its Association with Disease Progression and Disability
Ana Paula Kallaur et al.
MOLECULAR NEUROBIOLOGY (2017)
Genetic, Immune-Inflammatory, and Oxidative Stress Biomarkers as Predictors for Disability and Disease Progression in Multiple Sclerosis
Ana Paula Kallaur et al.
MOLECULAR NEUROBIOLOGY (2017)
Immunology of Multiple Sclerosis
Mireia Sospedra et al.
SEMINARS IN NEUROLOGY (2016)
Serum NSE level and disability progression in multiple sclerosis
Marcus W. Koch et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)
TNF AND ITS RECEPTORS IN THE CNS: THE ESSENTIAL, THE DESIRABLE AND THE DELETERIOUS EFFECTS
L. Probert
NEUROSCIENCE (2015)
Interrelation of Oxidative Stress and Inflammation in Neurodegenerative Disease: Role of TNF
Roman Fischer et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)
Targeting sTNF/TNFR1 Signaling as a New Therapeutic Strategy
Roman Fischer et al.
ANTIBODIES (2015)
Pharmacokinetic evaluation of fingolimod for the treatment of multiple sclerosis
Radu Tanasescu et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2014)
2014 Evidence-based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8) (vol 311, pg 507, 2014)
P. A. James
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Levels of soluble TNF-RII are increased in serum of patients with primary progressive multiple sclerosis
Nicolas Fissolo et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
Tumor necrosis factor beta NcoI polymorphism is associated with inflammatory and metabolic markers in multiple sclerosis patients
Ana Paula Kallaur et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2014)
Defining the clinical course of multiple sclerosis The 2013 revisions
Fred D. Lublin et al.
NEUROLOGY (2014)
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)
Paul A. James et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Sexual disparities in the incidence and course of MS
Riley Bove et al.
CLINICAL IMMUNOLOGY (2013)
Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS
Jigisha R. Patel et al.
ACTA NEUROPATHOLOGICA (2012)
Age at onset as a determinant of presenting phenotype and initial relapse recovery in multiple sclerosis
M. Cossburn et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis
Adam P. Gregory et al.
NATURE (2012)
Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria
Chris H. Polman et al.
ANNALS OF NEUROLOGY (2011)
TNFR1-induced activation of the classical NF-κB pathway
Harald Wajant et al.
FEBS JOURNAL (2011)
Age and disability accumulation in multiple sclerosis
A. Scalfari et al.
NEUROLOGY (2011)
Tumor Necrosis Factor-α Antagonist Reduces Apoptosis of Neurons and Oligodendroglia in Rat Spinal Cord Injury
Ke-Bing Chen et al.
SPINE (2011)
Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis
Antonio Diez-Ruiz et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Activation of TNF receptor 2 in microglia promotes induction of anti-inflammatory pathways
Caterina Veroni et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2010)
Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci
Philip L. De Jager et al.
NATURE GENETICS (2009)
Activation of caspase-8 by tumour necrosis factor receptor 1 is necessary for caspase-3 activation and apoptosis in oxygen-glucose deprived cultured cortical cells
Nahuai Badiola et al.
NEUROBIOLOGY OF DISEASE (2009)
Induction of serum soluble tumor necrosis factor receptor II (sTNF-RII) and interleukin-1 receptor antagonist (IL-1ra) by interferon beta-1b in patients with progressive multiple sclerosis
Manuel Comabella et al.
JOURNAL OF NEUROLOGY (2008)
Serum soluble TNF receptor I and II levels correlate with disease activity in IBD patients
Tanja Spoettl et al.
INFLAMMATORY BOWEL DISEASES (2007)
Cytokine changes during interferon-beta therapy in multiple sclerosis: Correlations with interferon dose and MRI response
Jerome J. Graber et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
TNFR1-induced NF-kappa B, but not ERK, p38MAPK or JNK activation, mediates TNF-induced ICAM-1 and VCAM-1 expression on endothelial cells
Zhigang Zhou et al.
CELLULAR SIGNALLING (2007)
Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
SM Grundy et al.
CIRCULATION (2005)
Cytokines in multiple sclerosis: from bench to bedside
J Imitola et al.
PHARMACOLOGY & THERAPEUTICS (2005)
Multiple sclerosis severity score -: Using disability and disease duration to rate disease severity
RHSR Roxburgh et al.
NEUROLOGY (2005)
Differential TNF-signaling in chronic inflammatory disorders
MH Holtmann et al.
CURRENT MOLECULAR MEDICINE (2004)
Role of TNF/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatments
G Kollias et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2002)
TNFα promotes proliferation of oligodendrocyte progenitors and remyelination
HA Arnett et al.
NATURE NEUROSCIENCE (2001)
分享论文
